Emcure Pharmaceuticals Limited shows robust Q4 FY26 results with 16.6% revenue growth and strategic portfolio expansion.
Emcure Pharmaceuticals Limited reports strong Q4 FY26 results with 16.7% revenue growth and 19.7% EBITDA margin.
IKS Health partners with Holyoke Medical Center to reduce administrative burden, leveraging AI and human expertise for better efficiency and patient care.
Dishman Carbogen Amcis Limited's subsidiary, CARBOGEN AMCIS Shanghai, successfully passes an unannounced GMP inspection by China’s NMPA.
Indegene identified as a leader in ISG Provider Lens for Life Sciences Digital Services, showcasing its expertise in digital transformation.
Wockhardt Limited reports strong FY 26 financials with Rs. 238 Cr profit before tax, marking significant growth in revenue and EBITDA.